Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Duconge

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Current Clinical Pharmacology|August 1, 2008
The case of biotech-derived product equivalence: much ado about nothing?Jorge Duconge
American Journal of Pharmaceutical Education|February 14, 2009
Applying organ clearance concepts in a clinical settingJorge Duconge
Pharmacogenomics|August 23, 2012
'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicineJorge Duconge, Gualberto Ruaño
Pharmacogenomics|October 3, 2015
Fixed-dose combination products and unintended drug interactions: urgent need for pharmacogenetic evaluationJorge Duconge, Gualberto Ruaño
Pharmacogenomics|June 15, 2018
Preventing the exacerbation of health disparities by iatrogenic pharmacogenomic applications: lessons from warfarinJorge Duconge, Gualberto Ruaño
Journal of Pharmacogenomics & Pharmacoproteomics|December 11, 2012
The Emerging Role of Admixture in the Pharmacogenetics of Puerto Rican HispanicsJorge Duconge, Gualberto Ruaño
Pharmacogenomics|August 19, 2016
Admixture and ethno-specific alleles: missing links for global pharmacogenomicsJorge Duconge, Gualberto Ruaño
Biomarkers in Medicine|November 26, 2013
CYP2D6's functional status associated with the length of hospitalization stay in psychiatric patients: a twist in the tale or evidence that matters?Jorge Duconge, Carmen L Cadilla
Current Clinical Pharmacology|March 2, 2017
Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery StentingJorge Duconge, Dagmar F Hernandez-Suarez
Future Cardiology|May 14, 2010
Implementing genotype-guided antithrombotic therapyRichard L Seip, Jorge Duconge, Gualberto Ruaño
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Current Clinical Pharmacology|August 1, 2008
The case of biotech-derived product equivalence: much ado about nothing?Jorge Duconge
American Journal of Pharmaceutical Education|February 14, 2009
Applying organ clearance concepts in a clinical settingJorge Duconge
Pharmacogenomics|August 23, 2012
'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicineJorge Duconge, Gualberto Ruaño
Pharmacogenomics|October 3, 2015
Fixed-dose combination products and unintended drug interactions: urgent need for pharmacogenetic evaluationJorge Duconge, Gualberto Ruaño
Pharmacogenomics|June 15, 2018
Preventing the exacerbation of health disparities by iatrogenic pharmacogenomic applications: lessons from warfarinJorge Duconge, Gualberto Ruaño
Journal of Pharmacogenomics & Pharmacoproteomics|December 11, 2012
The Emerging Role of Admixture in the Pharmacogenetics of Puerto Rican HispanicsJorge Duconge, Gualberto Ruaño
Pharmacogenomics|August 19, 2016
Admixture and ethno-specific alleles: missing links for global pharmacogenomicsJorge Duconge, Gualberto Ruaño
Biomarkers in Medicine|November 26, 2013
CYP2D6's functional status associated with the length of hospitalization stay in psychiatric patients: a twist in the tale or evidence that matters?Jorge Duconge, Carmen L Cadilla
Current Clinical Pharmacology|March 2, 2017
Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery StentingJorge Duconge, Dagmar F Hernandez-Suarez
Future Cardiology|May 14, 2010
Implementing genotype-guided antithrombotic therapyRichard L Seip, Jorge Duconge, Gualberto Ruaño
Pageof 10